Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2139
H.R.2139: Medicare Drug Price Negotiation Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 23, 2021
- Latest Major Action March 24, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
24 (All Democrats)
Bill Version
- Introduced in House - March 23, 2021
Bill Summary
Medicare Drug Price Negotiation Act This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs). Under current law, the Centers for Medicare & Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 24, 2021 |
Referred to the Subcommittee on Health.
|
March 23, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
March 23, 2021 |
Referred to the Subcommittee on Health.
|
March 23, 2021 |
Introduced in the House by Lloyd Doggett (D-Texas) |